(3R)-3-[2-(Methylthio)ethyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione

(3R)-3-[2-(Methylthio)ethyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione Struktur
1217780-31-8
CAS-Nr.
1217780-31-8
Englisch Name:
(3R)-3-[2-(Methylthio)ethyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione
Synonyma:
(3R)-3-[2-(Methylthio)ethyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione;(R)-3-(2-(Methylthio)ethyl)-3,4-dihydro-1h-benzo[e][1,4]diazepine-2,5-dione;1H-1,4-Benzodiazepine-2,5-dione, 3,4-dihydro-3-[2-(methylthio)ethyl]-, (3R)-;3-[2-(methylsulfanyl)ethyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2,5-dione;(3R)-3-[2-(methylsulfanyl)ethyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2,5-dione
CBNumber:
CB42554985
Summenformel:
C12H14N2O2S
Molgewicht:
250.32
MOL-Datei:
1217780-31-8.mol

(3R)-3-[2-(Methylthio)ethyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione Eigenschaften

Siedepunkt:
561.2±43.0 °C(Predicted)
Dichte
1.208±0.06 g/cm3(Predicted)
pka
12.66±0.40(Predicted)

Sicherheit

HazardClass  IRRITANT

(3R)-3-[2-(Methylthio)ethyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione Chemische Eigenschaften,Einsatz,Produktion Methoden

(3R)-3-[2-(Methylthio)ethyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


(3R)-3-[2-(Methylthio)ethyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 5)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Changzhou Hopschain Chemical Co.,Ltd. 0519-85528066 13775048983
sales@hopschem.com China 31557 55

  • (3R)-3-[2-(Methylthio)ethyl]-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione
  • 3-[2-(methylsulfanyl)ethyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2,5-dione
  • (3R)-3-[2-(methylsulfanyl)ethyl]-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2,5-dione
  • (R)-3-(2-(Methylthio)ethyl)-3,4-dihydro-1h-benzo[e][1,4]diazepine-2,5-dione
  • 1H-1,4-Benzodiazepine-2,5-dione, 3,4-dihydro-3-[2-(methylthio)ethyl]-, (3R)-
  • 1217780-31-8
Copyright 2019 © ChemicalBook. All rights reserved